FDA.reportPublic FDA data

cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection

RxCUI
2184142
RxNorm name
cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection
Display name
cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection
Full name
cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection
Term type
SCD
Status
DailyMed mapping
Updated
2026-06-04 23:39:19

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
be32f468-738b-40df-a425-591e12f65159cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection [PSN] · cilastatin 500 MG / imipenem 500 MG / relebactam 250 MG Injection [SCD]211These highlights do not include all the information needed to use RECARBRIO safely and effectively. See full prescribing information for RECARBRIO. RECARBRIO ® (imipenem, cilastatin, and relebactam) for injection, for intravenous use Initial U.S. Approval: 201920251209